Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease

Sameer Imtiaz, Kevin D Shield, Michael Roerecke, Andriy V Samokhvalov, Knut Lönnroth, Jürgen Rehm, Sameer Imtiaz, Kevin D Shield, Michael Roerecke, Andriy V Samokhvalov, Knut Lönnroth, Jürgen Rehm

Abstract

Meta-analyses of alcohol use, alcohol dosage and alcohol-related problems as risk factors for tuberculosis incidence were undertaken. The global alcohol-attributable tuberculosis burden of disease was also re-estimated.Systematic searches were conducted, reference lists were reviewed and expert consultations were held to identify studies. Cohort and case-control studies were included if there were no temporal violations of exposure and outcome. Risk relations (RRs) were pooled by using categorical and dose-response meta-analyses. The alcohol-attributable tuberculosis burden of disease was estimated by using alcohol-attributable fractions.36 of 1108 studies were included. RRs for alcohol use and alcohol-related problems were 1.35 (95% CI 1.09-1.68; I2: 83%) and 3.33 (95% CI 2.14-5.19; 87%), respectively. Concerning alcohol dosage, tuberculosis risk rose as ethanol intake increased, with evidence of a threshold effect. Alcohol consumption caused 22.02 incident cases (95% CI 19.70-40.77) and 2.35 deaths (95% CI 2.05-4.79) per 100 000 people from tuberculosis in 2014. Alcohol-attributable tuberculosis incidence increased between 2000 and 2014 in most high tuberculosis burden countries, whereas mortality decreased.Alcohol consumption was associated with an increased risk of tuberculosis in all meta-analyses. It was consequently a major contributor to the tuberculosis burden of disease.

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com

Copyright ©ERS 2017.

Figures

FIGURE 1
FIGURE 1
Estimated tuberculosis incidence rates per 100 000 people attributable to alcohol consumption by countries in 2014. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoeveron the part of the World Health Organization concerning the legal status of any country territory city or area or of its authoritiesor concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border linesfor which there may not yet be full agreement.
FIGURE 2
FIGURE 2
Estimated tuberculosis mortality rates per 100 000 people attributable to alcohol consumption by countries in 2014. The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country territory city or area or of its authorities or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement.
FIGURE 3
FIGURE 3
Estimated tuberculosis incidence rates per 100 000 people attributable to alcohol consumption in high-tuberculosis burden countries for 2000 and 2014.
FIGURE 4
FIGURE 4
Estimated tuberculosis mortality rates per 100 000 people attributable to alcohol consumption in high-tuberculosis burden countries for 2000 and 2014.

References

    1. World Health Organization. Global Tuberculosis Report. World Health Organization, Geneva, Switzerland, 2016.
    1. Institute for Health Metrics and Evaluation. GBD Compare. 2015. Date last acessed: July 19, 2016.
    1. Lönnroth K, Williams B, Stadlin S, et al. . Alcohol use as a risk factor for tuberculosis – a systematic review. BMC Public Health 2008; 8: 289.
    1. Rehm J, Samokhvalov AV, Neuman MG, et al. . The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health 2009; 9: 450.
    1. Rehm J, Baliunas D, Borges GL, et al. . The relation between different dimensions of alcohol consumption and burden of disease – an overview. Addiction 2010; 105: 817–843.
    1. Moher D, Liberati A, Tetzlaff J, et al. . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
    1. Tocque K, Bellis M, Beeching NJ, et al. . A case-control study of lifestyle risk factors associated with tuberculosis in Liverpool, North-West England. Eur Respir J 2001; 18: 959–964.
    1. World Health Organization. International Guide for Monitoring Alcohol Consumption and Related Harm. Geneva, World Health Organization, 2000.
    1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177–188.
    1. Cochran WG. The combination of estimates from different experiments. Biometrics 1954; 10: 101–129.
    1. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539–1558.
    1. Egger M, Smith GD, Schneider M, et al. . Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–634.
    1. World Health Organization. Global Tuberculosis Report. Geneva, World Health Organization, 2015.
    1. World Health Organization. Global Status Report on Alcohol and Health. Geneva, World Health Organization, 2014.
    1. Orsini NBR, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006; 6: 40–57.
    1. Kehoe T, Gmel G Jr, Shield K, et al. . Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms. Popul Health Metr 2012; 10: 6.
    1. Murray CJL, Lopez A. On the comparable quantification of health risks: lessons from the global burden of disease study. Epidemiology 1999; 10: 594–605.
    1. World Health Organization. Global status report on alcohol. Geneva, World Health Organization, 2004.
    1. Rehm J, Kehoe T, Gmel G, et al. . Statistical modeling of volume of alcohol exposure for epidemiological studies of population health: the example of the US. Popul Health Metr 2010; 8: 3.
    1. Gmel GJ, Shield KD, Frick H, et al. . Estimating uncertainty of alcohol-attributable fractions for infectious and chronic diseases. BMC Med Res Methodol 2011; 11: 48.
    1. World Health Organization. WHO TB burden estimates. 2016. Date last accessed: October 5, 2016.
    1. Stevens GA, Alkema L, Black RE, et al. . Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet 2016; 388: e19–e23.
    1. Gajalakshmi V, Peto R. Smoking, drinking and incident tuberculosis in rural India: population-based case-control study. Int J Epidemiol 2009; 38: 1018–1025.
    1. Jee SH, Golub JE, Jo J, et al. . Smoking and risk of tuberculosis incidence, mortality, and recurrence in South Korean men and women. Am J Epidemiol 2009; 170: 1478–1485.
    1. Amoakwa K, Martinson NA, Moulton LH, et al. . Risk factors for developing active tuberculosis after the treatment of latent tuberculosis in adults infected with human immunodeficiency virus. Open Forum Infect Dis 2015; 2: ofu120.
    1. Hemilä H, Kaprio J, Pietinen P, et al. . Vitamin C and other compounds in vitamin C rich foods in relation to risk of tuberculosis in male smokers. Am J Epidemiol 1999; 150: 632–641.
    1. Rosenman K, Hall N. Occupational risk factors for developing tuberculosis. Am J Ind Med 1996; 30: 148–154.
    1. Buskin SE, Gale JL, Weiss NS, et al. . Tuberculosis risk factors in adults in King County, Washington, 1988 through 1990. Am J Public Health 1994; 84: 1750–1756.
    1. Chen M, Deng J, Li W, et al. . Impact of tea drinking upon tuberculosis: a neglected issue. BMC Public Health 2015; 15: 515.
    1. Kolappan C, Subramani R. Association between biomass fuel and pulmonary tuberculosis: a nested case–control study. Thorax 2009; 64: 705–708.
    1. Ladefoged K, Rendal T, Skifte T, et al. . Risk factors for tuberculosis in Greenland: case-control study. Int J Tuberc Lung Dis 2011; 15: 44–49.
    1. Coker R, McKee M, Atun R, et al. . Risk factors for pulmonary tuberculosis in Russia: case-control study. BMJ 2006; 332: 85–87.
    1. Shetty N, Shemko M, Vaz M, et al. . An epidemiological evaluation of risk factors for tuberculosis in South India: a matched case control study. Int J Tuberc Lung Dis 2006; 10: 80–86.
    1. Crampin AC, Glynn JR, Floyd S, et al. . Tuberculosis and gender: exploring the patterns in a case control study in Malawi. Int J Tuberc Lung Dis 2004; 8: 194–203.
    1. Brown KE, Campbell AH. Tobacco, alcohol and tuberculosis. Br J Dis Chest 1961; 55: 150–158.
    1. Lewis D, Chamberlain J. Alcohol consumption and smoking habits in male patients with pulmonary tuberculosis. Br J Prev Soc Med 1963; 17: 149–152.
    1. Tekkel M, Rahu M, Loit HM, et al. . Risk factors for pulmonary tuberculosis in Estonia. Int J Tuberc Lung Dis 2002; 6: 887–894.
    1. Lienhardt C, Fielding K, Sillah JS, et al. . Investigation of the risk factors for tuberculosis: a case-control study in three countries in West Africa. Int J Epidemiol 2005; 34: 914–923.
    1. Spletter ED. Association between active pulmonary tuberculosis, tobacco smoke and alcohol consumption: a case control study (Academic thesis). Midwestern University, Glendale, USA, 2000.
    1. Dong B, Zhou Y. Smoking and alcohol consumption as risk factors of pulmonary tuberculosis in Chengdu: a matched case-control study. Hua Xi Yi Ke Da Xue Xue Bao 2001; 32: 104–106.
    1. Baker MA, Lin HH, Chang HY, et al. . The risk of tuberculosis disease among persons with diabetes mellitus: a prospective cohort study. Clin Infect Dis 2012; 54: 818–825.
    1. Hill PC, Jackson-Sillah D, Donkor SA, et al. . Risk factors for pulmonary tuberculosis: a clinic-based case control study in The Gambia. BMC Public Health 2006; 6: 156.
    1. Pokhrel AK, Bates MM, Verma SC, et al. . Tuberculosis and indoor biomass and kerosene use in Nepal: a case-control study. Environ Health Perspect 2010; 118: 558–564.
    1. Ruffino-Netto A, Caron-Ruffino M. Interação de fatores riscos em tuberculose. Rev Saude Publica 1979; 13: 119–122.
    1. Souza de Lima D, Morishi Ogusku M, Porto Dos Santos M, et al. . Alleles of HLA-DRB1* 04 Associated with Pulmonary Tuberculosis in Amazon Brazilian Population. PloS One 2016; 11: e0147543.
    1. Kim S, Crittenden K. Risk factors for tuberculosis among inmates: a retrospective analysis. Public Health Nurs 2005; 22: 108–118.
    1. Mori MA, Leonardson G, Welty TK. The benefits of isoniazid chemoprophylaxis and risk factors for tuberculosis among Oglala Sioux Indians. Ann Intern Med 1992; 152: 547–550.
    1. Inghammar M, Löfdahl CG, Winqvist N, et al. . Impaired pulmonary function and the risk of tuberculosis: a population-based cohort study. Eur Respir J 2011; 37: 1285–1287.
    1. Lin YT, Wu PH, Lin CY, et al. . Cirrhosis as a risk factor for tuberculosis infection – a nationwide longitudinal study in Taiwan. Am J Epidemiol 2014; 180: 103–110.
    1. Hsu WH, Kuo CH, Wang SS, et al. . Acid suppressive agents and risk of Mycobacterium tuberculosis: case–control study. BMC Gastroenterol 2014; 14: 91.
    1. Leegaard A, Riis A, Kornum JB, et al. . Diabetes, glycemic control, and risk of tuberculosis: a population-based case-control study. Diabetes Care 2011; 34: 2530–2535.
    1. Mahuad C, Bozza V, Pezzotto SM, et al. . Impaired immune responses in tuberculosis patients are related to weight loss that coexists with an immunoendocrine imbalance. Neuroimmunomodulation 2007; 14: 193–199.
    1. Moran-Mendoza O, Marion SA, Elwood K, et al. . Risk factors for developing tuberculosis: a 12-year follow-up of contacts of tuberculosis cases. Int J Tuberc Lung Dis 2010; 14: 1112–1119.
    1. Inghammar M, Ekbom A, Engström G, et al. . COPD and the risk of tuberculosis-a population-based cohort study. PloS One 2010; 5: e10138.
    1. Boccia D, Hargreaves J, De Stavola BL, et al. . The association between household socioeconomic position and prevalent tuberculosis in Zambia: a case-control study. PloS One 2011; 6: e20824.
    1. Oliveira HBD, Moreira Filho DDC. Recidivas em tuberculose e seus fatores de risco. Rev Panam Salud Pública 2000; 74: 232–241.
    1. Menezes AMB, Costa JDD, Gonçalves H, et al. . Incidência e fatores de risco para tuberculose em Pelotas, uma cidade do Sul do Brasil. Rev Bras Epidemiol 1998; 1: 50–60.
    1. Rehm J, Anderson P, Gual A, The tangible common denominator of substance use disorders: a reply to commentaries to Rehm et al. (2013). Alcohol Alcohol 2014; 49: 118–122.
    1. Simet SM, Sisson JH. Alcohol's effects on lung health and immunity. Alcohol Res 2015; 37: 199–208.
    1. Francisco J, Oliveira O, Felgueiras Ó, et al. . How much is too much alcohol in tuberculosis? Eur Respir J 2016; 49: 1601468.
    1. Shield K, Samokhvalov A, Rehm J. Global burden of tuberculosis and lower respiratory infections attributable to alcohol consumption in 2004. Int J Alcohol Drug Res 2013; 2: 11–18.
    1. Forouzanfar MH, Alexander L, Anderson HR, et al. . Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386: 2287–2323.
    1. Joshi PC, Applewhite L, Ritzenthaler JD, et al. . Chronic ethanol ingestion in rats decreases granulocyte-macrophage colony-stimulating factor receptor expression and downstream signaling in the alveolar macrophage. J Immunol 2005; 175: 6837–6845.
    1. Dannenberg AM. Immune mechanisms in the pathogenesis of pulmonary tuberculosis. Rev Infect Dis 1989; 11: S369–S378.
    1. Castro A, Lefkowitz DL, Lefkowitz SS. Effects of alcohol on murine macrophage function. Life Sci 1993; 52: 1585–1593.
    1. Dorio RJ, Forman HJ. Ethanol inhibition of signal transduction in superoxide production by rat alveolar macrophages. A proposed mechanism for ethanol related pneumonia. Ann Clin Lab Sci 1988; 18: 190–194.
    1. Rimland D, Hand WL. The effect of ethanol on adherence and phagocytosis by rabbit alveolar macrophages. J Lab Clin Med 1980; 95: 918–926.
    1. Rimland K. Mechanisms of ethanol-induced defects of alveolar macrophage function. Alcohol Clin Exp Res 1983; 8: 73–76.
    1. Bermudez L, Young LS. Ethanol augments intracellular survival of mycobacterium avium complex and impairs macrophage responses to cytokines. J Infect Dis 1991; 163: 1286–1292.
    1. Crews FT, Bechara R, Brown LA, et al. . Cytokines and alcohol. Alcohol Clin Exp Res 2006; 30: 720–730.
    1. Gamble L, Mason CM, Nelson S. The effects of alcohol on immunity and bacterial infection in the lung. Med Mal Infect 2006; 36: 72–77.
    1. Szabo G, Saha B. Alcohol's effect on host defense. Alcohol Res 2015; 37: 159–170.
    1. Szabo G. Alcohol and susceptibility to tuberculosis. Alcohol Health Res World 1997; 21: 39–41.
    1. Szabo G. Alcohol's contribution to compromised immunity. Alcohol Health Res World 1997; 21: 30–41.
    1. Lieber CS. Biochemical and molecular basis of alcohol-induced injury to liver and other tissues. N Engl J Med 1988; 319: 1639–1650.
    1. Dunne FJ. Alcohol and immune system. A causative agent in altering host defence mechanisms. BMJ 1989; 289: 543–544.
    1. Diel R, Schneider S, Meywald-Walter K, et al. . Epidemiology of tuberculosis in Hamburg, Germany: long-term population-based analysis applying classical and molecular epidemiological techniques. J Clin Microbiol 2002; 4: 532–539.
    1. Zolnir-Dovc M, Poljak M, Erzen D, et al. . Molecular epidemiology of tuberculosis in Slovenia: results of a one-year (2001) nation-wide study. Scand J Infect Dis 2003; 35: 863–868.
    1. Classen CN, Warren R, Richardson M, et al. . Impact of social interactions in the community on the transmission of tuberculosis in a high incidence area. Thorax 1999; 54: 136–140.
    1. World Health Organization. The End TB Strategy: Global Strategy and Targets for Tuberculosis Prevention, Care and Control After 2015. Geneva, World Health Organization, 2015.
    1. Lönnroth K, Jaramillo E, Williams BG, et al. . Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009; 68: 2240–2246.
    1. Uplekar M, Weil D, Lönnroth K, et al. . WHO's new End TB Strategy. Lancet 2015; 385: 1799–1801.
    1. Lönnroth K, Castro KG, Chakaya JM, et al. . Tuberculosis control and elimination 2010–50: cure, care, and social development. Lancet 2010; 375: 1814–1829.
    1. Anderson P, Chisholm D, Fuhr D. Effectiveness and cost-effectiveness of policies and programmes to reduce the harm caused by alcohol. Lancet 2009; 373: 2234–2246.
    1. World Health Organization. Closing the gap in a generation: health equity through action on the social determinants of health. Commission on Social Determinants of Health Final Report. Geneva, World Health Organization, 2008.
    1. Lönnroth K, Migliori GB, Abubakar I, et al. . Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J 2015; 45: 928–952.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe